Clinical Trial Update: Personalized AZithromycin/metronidAZole Therapy in Pediatric Crohn's Disease (CD) [Phase 2]

View source ↗

Summary

A Phase 2 trial assessing personalized azithromycin and metronidazole therapy for pediatric Crohn's disease was terminated, with results posted in 2025.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease

Drugs mentioned

• Azithromycin (azithromycin)
• METRONIDAZOLE (Metronidazole)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Crohn Disease, Pediatric Crohns Disease | Phase 2 | Status: TERMINATED | Results posted: 2025-06-29